What Is RGCC Cancer Testing?

RGCC (Research Genetic Cancer Centre®) testing is an advanced circulating tumor cell (CTC) and biomarker analysis performed using a simple blood draw.

Rather than diagnosing cancer, RGCC testing is designed to identify cellular activity patterns associated with potential cancer processes. This provides early biological insight for proactive individuals. This also supports long-term monitoring strategies in post-treatment care

All RGCC tests are processed through internationally recognized laboratories using advanced cellular and molecular analysis methods.

How RGCC Cancer Testing Differs From Standard Cancer Screening

RGCC cancer testing is fundamentally different from traditional cancer screening methods such as imaging, biopsies, or tumor marker blood tests.

While conventional screening focuses on identifying existing tumors, RGCC testing analyzes circulating tumor cells (CTCs) and cancer-related biomarkers that may reflect early biological activity.

RGCC testing uses a simple blood draw and does not rely on imaging or radiation. This testing is intended for proactive insight and monitoring, not diagnosis.

Who May Benefit From Cancer Testing?

RGCC cancer testing may be appropriate for individuals who are currently asymptomatic as well as individuals who have completed their cancer treatment.

Asymptomatic Individuals Seeking Proactive Screening Insight

That would include individuals with a family history of cancer. This would also include those pursuing a preventive or longevity-focused wellness approach. Those individuals seeking deeper biological insight beyond standard wellness labs would also be interested in this testing.

Individuals in Cancer Follow-Up Care will also benefit from this testing.

This would include individuals who have completed cancer treatment and who are currently asymptomatic, those interested in trend monitoring over time, and  those individuals working alongside their oncology team for additional insight

RGCC testing is not recommended for individuals with active symptoms or as a replacement for imaging, biopsies, or oncologic care.

Who Is Not A Good Candidate for RGCC Cancer Testing

RGCC cancer testing is not for everyone. It should not be used by individuals who have active or unexplained symptoms. RGCC will not provide a definitive cancer diagnosis. Finally, RGCC should not be used by anyone who needs urgent medical evaluation. In these situations, diagnostic testing through imaging, biopsies, or oncology referral is the appropriate next step.

How RGCC Cancer Testing Works at NAWI Wellness

Personalized Consultation

Your visit begins with a clinician-led consultation to determine whether RGCC testing is appropriate for your goals and medical history.

Targeted Test Selection

RGCC offers multiple test panels. Dr. Dean and the NAWI team will help you select the most relevant option based on your situation.

Simple Blood Draw

Blood is drawn in-office and shipped to the RGCC laboratory for analysis.

Results Review & Guidance

Once results are available, Dr. Dean and the NAWI team will review the results with you in context.  They’ll tell you what the findings may indicate, how results can be tracked over time, and, most importantly, whether further evaluation or collaboration with your physician is appropriate.

Why Choose NAWI for RGCC Cancer Testing?

NAWI Wellness is an Official RGCC Provider. That means that the NAWI staff has been certified by RGCC to offer this testing.

NAWI supports informed decision-making, not fear-based testing. NAWI’s approach to wellness utilizes an integrative, client-centered approach.

NAWI offers a private, supportive environment, focusing on education, clarity, and responsible use of advanced testing. 

Important Limitations to Understand 

RGCC testing does not diagnose cancer. It also does not replace imaging, biopsies, or oncology care. It is very important to understand that RGCC is not appropriate for evaluating active symptoms. RGCC is best viewed as a proactive or supportive tool, used responsibly and under medical guidance.

Schedule a Cancer Testing Consultation in Naples, FL

NAWI serves clients throughout Naples, Collier County, and Southwest Florida, offering a private, clinician-guided approach to advanced wellness and cancer-related testing.

If you are interested in proactive screening insight or supportive monitoring after cancer treatment, schedule a RGCC Cancer Testing consultation at Naples Aesthetic & Wellness Institute to determine whether RGCC testing is right for you.

Call NAWI at 239-202-0441 or book online by clicking the ‘Book Now’ box to get started

Frequently Asked Questions About RGCC Cancer Testing

What is the RGCC?

RGCC, or Research Genetic Cancer Center, was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively.  For more information about RGCC click here.

Is RGCC cancer testing a cancer diagnosis?

No. RGCC testing is not diagnostic and cannot confirm or rule out cancer.

Can RGCC testing detect cancer early?

RGCC testing may provide early biological insight, but results must be interpreted cautiously and do not replace standard screening or diagnostic tests.

Do I need symptoms to qualify for testing?

No. RGCC testing is intended for asymptomatic individuals or those in post-treatment monitoring.

Will my oncologist accept RGCC results?

RGCC results are often used as adjunctive information. Acceptance of RGCC results varies by provider.

What is the Science Behind Circulating Tumor Cell Analysis?

Circulating tumor cells are rare cells that may enter the bloodstream from tumor activity. RGCC testing focuses on identifying and characterizing these cells using advanced laboratory techniques.

While the presence of circulating tumor cells does not confirm cancer, tracking cellular activity patterns over time may provide valuable longitudinal insight, particularly in post-treatment monitoring.

All results must be interpreted within the context of an individual’s medical history and in collaboration with qualified healthcare providers.